ESRRG and breast cancer: These results indicated that miR-320a was negatively correlated with the expression of ARPP-19 and ERRγ, and their downstreams c-Myc and Cyclin D1 in tamoxifen-resistant ER+ breast cancer cells, which may relate to tamoxifen resistance.